Morbidity and Mortality Patterns of Hospitalised Adult HIV/AIDS Patients in the Era of Highly Active Antiretroviral Therapy: A 4-year Retrospective Review from Zaria, Northern Nigeria
Table 1
Baseline characteristics of hospitalised HIV/AIDS patients in relation to antiretroviral therapy status.
Characteristics
No HAART
Receiving HAART
All patients
Age in years-median (IQR)
35 (29, 43)
40 (34, 48)
36 (30, 45)
Minimum–Maximum
15–68
23–60
15–68
Gender (%)
Male
77 (50.7)
32 (58.2)
109 (52.7)
Female
75 (49.3)
23 (41.8)
98 (47.3)
Marital status (%)
Ever married
120 (78.9)
44 (80.4)
164 (79.3)
Never married
32 (21.1)
11 (19.6)
43 (20.7)
Occupation (%)
Professionals/Civil servants
37 (24.3)
14 (25.5)
51 (24.6)
Unemployed housewives
52 (34.2)
12 (21.8)
64 (30.9)
Artisans
20 (13.2)
7 (12.7)
27 (13)
Students
13 (8.6)
6 (10.9)
19 (9.3)
Traders/Business
11 (7.2)
8 (14.5)
19 (9.3)
Farmer
6 (3.9)
2 (3.6)
8 (3.9)
Others
13 (8.6)
7 (12.7)
20 (9.7)
Risk factors for HIV (%)
Heterosexual
142 (93.4)
50 (90.9)
192 (92.8)
Homosexual
3 (2.0)
2 (36.4)
5 (2.4)
Multiple sexual partners
21 (13.8)
13 (23.6)
34 (16.4)
Blood transfusion
7 (4.6)
3 (5.5)
10 (4.8)
Symptom duration in days
Median (IQR)
21 (14, 90)
60 (14, 90)
30 (14, 90)
Hospital stay in days
Median (IQR)
14 (5, 24)
14 (7, 30)
14 (7, 28)
Packed cell volume
Median (IQR)
27 (20, 33)
24 (17, 34)
27 (19, 34)
PCV levels (%)
24%
22 (31.9)
19 (48.7)
41 (38%)
24–29%
20 (29.0)
4 (10.3)
24 (22.2%)
30%
27 (39.1)
16 (41.0)
43 (39.8%)
Total WBC count
Median (IQR)
5.0 (3.7, 6.5)
4.7 (3.9, 6.1)
4.9 (3.7, 6.5)
Platelet count-Median (IQR)
246 (145, 331)
230 (157, 271)
233 (142, 310)
CD4 cell count-Median (IQR)
136 (5, 201)
137 (56, 190)
136 (56, 199)
CD4 levels (%)
50
11 (23.9)
9 (23.7)
20 (23.8%)
50–200
23 (50.0)
21 (55.2)
44 (52.4%)
201–350
7 (15.2)
6 (15.8)
12 (14.3%)
351
5 (10.9)
2 (5.3)
7 (8.3%)
NB—: number; IQR: interquartile range; WBC: white blood cell; PCV: packed cell volume. No statistical significant differences were observed in demographic and laboratory variables between HAART experienced and ART naive patients (, all analyses).